Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study

This publication has 20 references indexed in Scilit:

• Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study
  Journal of Neurology, Neurosurgery & Psychiatry, 2003
• Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2003
• Evaluating drug treatments for Parkinson's disease: how good are the trials?
  BMJ, 2002
• Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments
  Journal of Neurology, Neurosurgery & Psychiatry, 2002
• Twelve‐month safety of entacapone in patients with Parkinson’s disease
  European Journal of Neurology, 2001
• Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients
  Annals of Neurology, 1997
• A Double-Blind Pharmacokinetic and Clinical Dose—Response Study of Entacapone as an Adjuvant to Levodopa Therapy in Advanced Parkinson's Disease
  Clinical Neuropharmacology, 1996
• The response to levodopa in parkinson's disease: Imposing pharmacological law and order
  Annals of Neurology, 1996
• The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease
  Quality of Life Research, 1995
• General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase
  General Pharmacology: The Vascular System, 1994